Mythical Foreign Investors Frequently Purchase Stakes at High Prices, Kedapharma's Profit Margin Exceeds 90%, and Promotion Meeting Attendance Significantly Outstrips Industry Peers | IPO Observation
In recent days, Kedapharma Pharmaceutical Co., Ltd. (hereinafter referred to as \"Kedapharma\") has made new progress in its listing process on the sci-tech innovation board, having submitted a respon